Navigation Links
Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
Date:4/30/2008

SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report first quarter 2008 financial results after the NASDAQ Global Market closes on Wednesday, May 7, 2008. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the first quarter 2008 financial results and to provide a corporate update.

The conference call may be accessed by dialing 866.356.3095 for domestic callers and 617.597.5391 for international callers. Please specify to the operator that you would like to join the "Arena First Quarter Earnings Call." The participant code for the call is 65484912. The conference call will be webcast live under the investor relations section of Arena's website at http://www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, incl
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Arena Pharmaceuticals Announces Public Offering of Common Stock
3. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
4. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/5/2009)... significant scientific advances in the field of blood cancers, ... of how certain diseases progress in order to discover ... care. Research presented today at the 51st Annual Meeting ... therapies for managing multiple myeloma, the importance of advance ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- They,re not ... bad reactions to certain holiday traditions and need to ... to the American College of Allergy, Asthma and Immunology ... may choose to decorate with artificial plants, but both ...
(Date:12/5/2009)... most unusual places, and to do everything from growing mushrooms, making wine ... ... Who would have thought that your wine, water and vegetables would have ... a new line of turbines, for industry end users, not wind farms. ...
(Date:12/4/2009)... Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd ... Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive ... at the 2009,Goldman Sachs U.S. Financial Services Conference being ... City on Tuesday, December 8, 2009. ,, ...
Breaking Medicine News(10 mins):Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
... WOONSOCKET, R.I., Feb. 4 CVS Caremark (NYSE: ... Caremark Customer Care Centers have again been recognized ... Associates Certified Call Center Program(SM). This is the ... distinction, which acknowledges Caremark,s call center operations as ...
... Americas, Inc., an international,leader in mouth and body ... Group Limited to demonstrate consumers, desires to purchase,products ... The 1,957 people who participated in ... asked about their relationship with their dental hygienist;,the ...
... 4 Dr. Xavier Azar is proud to present his ... published by AuthorHouse ), a highly educational book for parents ... after birth and continuing on through one,s adult life."When the ... care preventive therapies as well as informing the masses about ...
... functional decline, could ward off osteoarthritis, study says ... Exercise may play a key role in helping ... osteoarthritis (OA), two new studies show. , , After ... six-week progressive strengthening program showed much improvement in ...
... while expert notes exercise best antidote , , WEDNESDAY, Feb. 4 (HealthDay ... of a heart attack in middle-aged women, a new study finds. ... associated with a higher risk for heart attack," said Dr. Judith ... issue of BMJ . "Until now, that data has been ...
... The Blue Foundation for a Healthy Florida ... Shield of Florida (BCBSF), recently approved $499,418 for grants ... epidemic,s impact on children and health care in Florida. ... physical activity.The grants are part of The Blue Foundation,s ...
Other Medicine News:Health News:Caremark Customer Care Centers Recognized for Customer Satisfaction Excellence by J.D. Power and Associates Certified Call Center Program(SM) 2Health News:Study Reveals Consumers Want to Buy Products That Dental Hygienists Recommend 2Health News:'When the Tooth Fairy is Not Enough': A Collection of the Most Common Misconceptions in Oral Health Care Set in a Parent-Friendly Book 2Health News:Exercise Key Player in Knee Replacement Recovery 2Health News:High Resting Heart Rate Spells Trouble for Women 2Health News:Embrace a Healthy Florida Pumps Up Studies on Childhood Obesity 2Health News:Embrace a Healthy Florida Pumps Up Studies on Childhood Obesity 3
(Date:12/4/2009)... Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced ... Plan of Reorganization and related amended Disclosure Statement with the ... ,, A hearing to consider the adequacy of the ... the hearing on the confirmation of the Plan scheduled for ...
(Date:12/4/2009)... Amber Pharmacy announced today that it received accreditation ... for specialized pharmacy services. For nearly 15 years, Amber ... to meet the unique needs of specialized conditions. Amber ... to transplant programs. They work with over 170 transplant ...
(Date:12/4/2009)... Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: ... enrolled in the company,s Phase II-b, dose escalation, clinical ... traumatic brain injury (TBI). Oxycyte is the Company,s perfluorocarbon ... invaluable importance in improving the outcome of patients with ...
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Amber Pharmacy Earns Accreditation From ACHC 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 1The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 2Working Parents Take the Panic Out of Flu Pandemic 60763 1Working Parents Take the Panic Out of Flu Pandemic 60763 2WaferGen Names Christopher Sears Ph D Architect of High Value Molecular Diagnostics and Computational Biology Platforms to Companys Scientific Adv 14734 1WaferGen Names Christopher Sears Ph D Architect of High Value Molecular Diagnostics and Computational Biology Platforms to Companys Scientific Adv 14734 2WaferGen Names Christopher Sears Ph D Architect of High Value Molecular Diagnostics and Computational Biology Platforms to Companys Scientific Adv 14734 3WaferGen Names Christopher Sears Ph D Architect of High Value Molecular Diagnostics and Computational Biology Platforms to Companys Scientific Adv 14734 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: